Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Q1 2026 Overall Financial Results
BIIB logo

Biogen’s Growth Products Surge 12% as Q1 Earnings Per Share Jump 18%

BIIB8-KFiling Date: 4/29/2026
Biogen Inc.
Description

What this story covers

Biogen’s Q1 2026 results show a 2% revenue increase and 18% EPS growth, driven by a 12% rise in new growth products. Despite higher R&D spending and revised guidance for acquisitions, robust cash flow supports its strategic transition.

Story snapshot

CompanyBiogen Inc.
TickerBIIB
VariantStandard detailed
Duration5:17
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000875045-26-000042
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in